pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
GILEAD · news · pharmadog
← back to GILEAD
News mentioning GILEAD
127
stories
Jul 27, 26
AstraZeneca has no plans to ramp up dealmaking in wake of Wainua failure
biospace
Jul 27, 26
Argenx deepens immuno expertise with $2.2B Forte Biosciences buy
biospace
Jul 27, 26
Legend Biotech CEO abruptly steps down without permanent replacement
fiercebiotech
Jul 27, 26
Lilly, AbbVie climb aboard in vivo CAR T train—but safety remains a hurdle
biospace
Jul 24, 26
STAT+: Pharmalittle: We’re reading about an FDA panel and peptides, a Merck license for an HIV pill, and more
stat
Jul 24, 26
Study of Yescarta patients reveals genetic red flags for CAR-T therapy side effects
fiercebiotech
Jul 24, 26
STAT+: Merck strikes voluntary licensing deals in poor countries for an experimental HIV prevention pill
stat
Jul 24, 26
Merck stages expanded access to monthly HIV PrEP pill ahead of approval
fiercebiotech
Jul 23, 26
STAT+: European regulators take steps to bolster clinical trial transparency
stat
Jul 23, 26
STAT+: Pharmalittle: We’re reading about Lilly obesity drug data, a push for FDA to ban DTC ads, and more
stat
Jul 23, 26
STAT+: FDA is urged by advocacy group to ban DTC prescription drug ads
stat
Jul 23, 26
Roche's late stage pipeline 'so full,' CEO Schinecker not feeling pressure to add on
biospace
Jul 23, 26
Biopharma layoffs must double in H2 for 2026 to match 2025 cuts
biospace
Jul 22, 26
New study supports testing of Merck’s Ebola vaccine in DRC outbreak
stat
Jul 22, 26
Congo’s Ebola outbreak has killed over 1,000 people
stat
Jul 22, 26
Repligen strikes $1.5B BioLife buyout to bag cell therapy product pharmas rely on
biospace
Jul 22, 26
Summit counters PD-1/VEGF skeptics; Celldex drug fails skin disease study
biopharma dive
Jul 22, 26
STAT+: Pharmalittle: We’re reading about Trump’s plan for tariffs on generics, a Merck and Gilead HIV pill, and more
stat
Jul 21, 26
Gilead and Merck provide HIV data; Dimension Capital announces $800M fund
endpoints
Jul 21, 26
Recon: Novo sues Lilly over weight-loss drug ads; Gilead, Merck say HIV pill keeps HIV suppressed in two Phase 3 trials
raps
Jul 20, 26
How Kyverna rode CAR T’s autoimmune wave to the FDA’s door
biospace
Jul 16, 26
Spurred by deep cuts and M&A activity, H1 layoffs could oust 14,000+ in biopharma
biospace
Jul 15, 26
STAT+: Glenmark to pay $29.6 million to settle price-fixing allegations in long-running battle with states
stat
Jul 15, 26
STAT+: Pharmalittle: We’re reading about a Biogen Alzheimer’s drug, skyrocketing 340B drug sales, and more
stat
Jul 14, 26
STAT+: FTC settles lawsuit with CVS Caremark over charges it manipulated insulin prices, impeded access
stat
Jul 14, 26
STAT+: Sales from controversial U.S. drug discount program rose to $100 billion last year
stat
Jul 14, 26
STAT+: Pharmalittle: We’re reading about a battle between Lilly and Teva, psychedelic drugs, and more
stat
Jul 13, 26
STAT+: AIDS activists slam Biden R&D deal with Gilead over HIV prevention drug patents
stat
Jul 6, 26
Novartis to acquire ADC developer in a deal worth up to $1.5B
biopharma dive
Jul 6, 26
The race for an Ebola therapy begins
stat
← prev
page 3 of 5
next →
